Peter Moldt

Peter Moldt is a Senior Partner at Novo Ventures in San Francisco, California, with a focus on investing in various stages and sectors within the healthcare industry. He has successfully invested in companies like INBRACE, Bolt Biotherapeutics, ViewPoint Therapeutics, and Arch Oncology, contributing to their growth and success in Series A to Series D funding rounds.